Evan Ong, MD, MS, FACS
Dr. Evan S. K. Ong is a general surgeon and surgical oncologist at the Swedish Medical Center in Seattle, Washington. He specializes in the use of state-of-the-art surgical techniques, including minimally invasive and robotic surgery for hepatic and pancreatic tumors, hyperthermic intraperitoneal chemoperfusion (HIPEC) for peritoneal mesothelioma and other surface malignancies that have disseminated to the peritoneal cavity, and microwave and bipolar radiofrequency ablation.
Dr. Ong’s philosophy of care is “Qui Audet … Cura”, which translates into “Who dares… cares.”[1]
Education and Career
Dr. Ong earned his medical degree at the Albert Einstein College of Medicine, then completed his internship and residency in General Surgery at the University of Illinois at Chicago Medical Center. He completed his fellowship in Surgical Oncology at Roswell Park Cancer Institute. He is board-certified by the American Board of Surgery and by the American Board of Internal Medicine in Hospice and Palliative Medicine.[1]
Research
Dr. Ong has contributed to numerous studies examining the use of intraperitoneal and intra-arterial chemotherapy in combination with surgery, as well as other areas of oncological interest.
His publications include:[footnote num=”1″}
- Ong ES, Poirier M, Espat NJ. Hepatic intra-arterial chemotherapy. Ann Surg Oncol. 2006 Feb;13(2):142-9. Epub 2006 Jan 18. Review.
- Chi A, Jang S, Welsh J, Nguyen N, Ong E, Gobar L, Komaki R. Feasibility of Helical Tomothraphy in Sterotactic Body Radiation Therapy for Centrally Located Early Stage Non-small Cell Lung Cancer or Lung Metastases. Int J Radiat Oncol Biol Phys. 2011 Jan 19.
- Alejandro Garcia-Uribe, Cheng-Chung Chang, Murat Kaya Yapici, Jun Zou, Member, IEEE, Bhaskar Banerjee, Garcia-Uribe A, Chang C, Yapici M, Kuczynski J, Ong E, Marner E, Wang L, High-Transmission -Efficiency and Side-Viewing Micro OIDRS Probe for Fast and Minimally Invasive Tumor Margin Detection. IEEE Sensor Journal, 2011 April 11(4): 891-6.
- Konstantantinidis IT, Young C, Tsikitis VL, Lee EM, Jie T, Ong E. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion: The University of Arizona Early Experience. World J Gastrointest Surg. 2012;. 4 (6): 135-40
- Ong E, Diven C, Abrams A, Lee E, Mahadevan D. Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Malignant Ascites from GIST. (accepted) JOPC
- Turaga K, Levine E, Barone R, Sticca R, Petrelli N, Lambert L, Nash G, Morse M, Abdel-Misih R, Alexander HR, Attiyeh F, Bartlett D, Bastidas A, Blazer T, Chu Q, Chung K, Dominguez-Parra L, Espat NJ, Foster J, Fournier K, Garcia R, Goodman M, Hanna N, Harrison L, Hoefer R, Holtzman M, Kane J, Labow D, Li B, Lowy A, Mansfield P, Ong E, Pameijer C, Pingpank J, Quinones M, Royal R, Salti G, Sardi A, Shen P, Skitzki J, Spellman J, Stewart J and Esquivel J. Consensus Guidelines from The American Society of Peritoneal Surface Malignancies on Standardizing the Delivery of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer Patients in the United States. Annals of Surg Onc. June 2013.
- HIPEC treatment delivers high dose of chemotherapy to cancer cells – New Day NW
